Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer

Johnny Kao, Eric M. Genden, Vishal Gupta, Edelweiss L. Policarpio, Ryan J. Burri, Michael Rivera, Vivek Gurudutt, Peter M. Som, Marita Teng, Stuart H. Packer

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences